U.S. Markets closed
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • Dow 30

    34,935.47
    -149.06 (-0.42%)
     
  • Nasdaq

    14,672.68
    -105.59 (-0.71%)
     
  • Russell 2000

    2,226.25
    -13.78 (-0.62%)
     
  • Crude Oil

    73.81
    +0.19 (+0.26%)
     
  • Gold

    1,816.90
    -18.90 (-1.03%)
     
  • Silver

    25.55
    -0.23 (-0.90%)
     
  • EUR/USD

    1.1872
    -0.0024 (-0.2018%)
     
  • 10-Yr Bond

    1.2390
    -0.0300 (-2.36%)
     
  • Vix

    18.24
    +0.54 (+3.05%)
     
  • GBP/USD

    1.3908
    -0.0050 (-0.3547%)
     
  • USD/JPY

    109.6500
    +0.1890 (+0.1727%)
     
  • BTC-USD

    41,663.83
    +156.48 (+0.38%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • FTSE 100

    7,032.30
    -46.12 (-0.65%)
     
  • Nikkei 225

    27,283.59
    -498.83 (-1.80%)
     

Tellurian (TELL) to Build Electric-Driven Pipeline in Lousiana

·3 min read

Tellurian Inc. TELL, through its wholly-owned subsidiary, Driftwood Pipeline LLC, filed an application with the Federal Energy Regulatory Commission (“FERC”) to construct and operate the newly-proposed Line 200 and 300 pipeline project in Louisiana.

The Line 200 pipeline project involves a 37-mile dual 42-inch interstate pipeline system, which will originate at Ragley in Beauregard Parish and end at Carlyss in Calcasieu Parish of Louisiana. The pipeline will be constructed in two phases, of which phase one is Line 200 and phase two is Line 300. Notably, Line 300 involves a 31-mile pipeline, which could be in service by December 2026.

The new pipeline system will offer increased availability of supplies to address the rising demand from the industrial, petrochemical, manufacturing and Liquefied Natural Gas ("LNG") facilities in and around the Lake Charles area. It is expected to connect the supply gap located north of Lake Charles to the demand located within and south of the area.

As part of the design, Driftwood Pipeline is planning to deploy electric-driven compression, which will be supplied by Baker Hughes BKR, to reduce the pipeline’s carbon emissions by more than 99%. Markedly, the project will result in a significant reduction of nearly one million tons of direct greenhouse gas emissions per year.

Tellurian is planning to sign a long-term lease for its proposed Driftwood LNG facility and start preparing the site for construction. Notably, the Driftwood LNG export terminal will be located near the proposed Line 200 and Line 300 expansion pipeline system. The pipeline expansion is part of a larger system network planned by the company to supply LNG to its Driftwood facility.

The latest pipeline design offers significant results in emission reduction and takes Tellurian a step ahead to implement its overall strategy to support and maintain the world’s energy requirements and environmental conditions. The company expects to receive FERC approval by the end of 2022 and plans to begin construction activities in 2024.

Company Profile & Price Performance

Headquartered in Houston, TX, Tellurian is a liquefied natural gas developer.

Shares of the company have outperformed the industry in the past six months. Its stock has gained 203.7% compared with the industry’s 34.8% growth.

Zacks Investment Research
Zacks Investment Research

Image Source: Zacks Investment Research

Zacks Rank & Stocks to Consider

The company currently carries a Zack Rank #3 (Hold).

Some better-ranked players in the energy space are Repsol SA REPYY and Exxon Mobil Corporation XOM, each currently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Over the past 60 days, the Zacks Consensus Estimate for Repsol’s 2021 earnings has been raised by 21.8%.

Exxon’s earnings for 2021 are expected to rise 13% year over year.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Exxon Mobil Corporation (XOM) : Free Stock Analysis Report

Repsol SA (REPYY) : Free Stock Analysis Report

Baker Hughes Company (BKR) : Free Stock Analysis Report

Magellan Petroleum Corporation (TELL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research